Beijing SL Pharmaceutical Co., Ltd. (SHE:002038)

China flag China · Delayed Price · Currency is CNY
6.46
+0.01 (0.16%)
Feb 27, 2026, 3:04 PM CST
Market Cap6.64B -9.3%
Revenue (ttm)578.61M -26.0%
Net Income83.77M +1.7%
EPS0.08 -2.5%
Shares Out1.03B
PE Ratio81.65
Forward PEn/a
Dividend0.02 (0.31%)
Ex-Dividend DateJul 4, 2025
Volume11,887,207
Average Volume27,119,128
Open6.59
Previous Close6.45
Day's Range6.40 - 6.59
52-Week Range5.98 - 8.74
Beta0.37
RSI32.98
Earnings DateApr 23, 2026

About Beijing SL Pharmaceutical

Beijing SL Pharmaceutical Co., Ltd., a biopharmaceutical company, research, development, and production of genetic engineering and related drugs People’s Republic of China and internationally. The company’s finished formulations include temozolomide; arsenic trioxide; lenalidomide capsules; pegylated human granulocyte-stimulating factor injection; human granulocyte-cell stimulating factor injection; recombinant human basic fibroblast growth factor for external use recombinant human basic fibroblast growth factor gel; human interleukin-11; arsen... [Read more]

Sector Healthcare
Founded 1994
Employees 889
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002038
Full Company Profile

Financial Performance

Financial Statements